福元医药：公司部分药品拟中选接续采购

Core Viewpoint - The company has participated in the national organized procurement for drugs whose agreements are expiring, with several drugs expected to be selected in this follow-up procurement [1] Group 1 - The main drugs expected to be selected include Ezetimibe tablets, Telmisartan tablets, Gliclazide sustained-release tablets, Olmesartan medoxomil tablets, and Repaglinide tablets [1]